Peggy Carter

Peggy Carter has a strong background in regulatory affairs, with a focus on the medical devices and diagnostics industries. Peggy most recently held the position of Corporate VP Regulatory at Caris Life Sciences starting in 2022. Prior to that, they worked at Novartis from 2018 to 2022, serving as the VP, Head Regulatory Affairs for both Medical Devices RA Precision Medicine and Medical Devices. From 2014 to 2022, Peggy held various roles at Novartis Oncology Development CDx, including Global Head Drug Regulatory Affairs and Senior Director Regulatory Affairs. Peggy also worked at Novartis Molecular Diagnostics from 2011 to 2022 as the Director Regulatory Affairs. Before joining Novartis, Peggy gained experience at Ventana Medical Systems, where they were a Senior Manager in Regulatory Affairs from 2006 to 2010, and at r2 Diagnostics as the Director of Product Development from 2002 to 2006. Peggy began their career in the field as a Process Development Engineer at BioPool US, INC in 2001. Peggy holds a Doctoral Fellow position at Louisiana State University Health Sciences Center/FeistWeiller Cancer Center from 1998 to 1999. Overall, Peggy has a diverse range of experience in regulatory affairs and a track record of success in the industry.

Peggy Carter's education history begins with their Bachelor of Arts (B.A.) degree in Biology, which they obtained from Earlham College between the years 1986 and 1990. Peggy then pursued further studies and earned a Doctorate (PhD) in Biochemistry and Molecular Biology from the Louisiana State University Health Sciences Center from 1993 to 1998. In 2008, Peggy attended the Regulatory Affairs Professionals Society for a short period, where they completed a Regulatory Affairs Certification (RAC) program. Additionally, they obtained another RAC certification in December 2008 from the Regulatory Affairs Certification Program. Most recently, in October 2017, Peggy completed the regulatory affairs certification program once more, obtaining the RAC-US certification.